• 2933 Citations
  • 22 h-Index
19962020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Cystic Fibrosis Medicine & Life Sciences
Cystic Fibrosis Transmembrane Conductance Regulator Medicine & Life Sciences
Lung Medicine & Life Sciences
Mucus Medicine & Life Sciences
Mucociliary Clearance Medicine & Life Sciences
Lung Diseases Medicine & Life Sciences
Epithelial Sodium Channels Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2000 2020

Research Output 1996 2019

Critical Care of the Adult Patient With Cystic Fibrosis

King, C. S., Brown, A. W., Aryal, S., Ahmad, K. & Donaldson, S. H., Jan 1 2019, In : Chest. 155, 1, p. 202-214 13 p.

Research output: Contribution to journalReview article

Critical Care
Cystic Fibrosis
Patient Care
Physicians
Exocrine Pancreatic Insufficiency

Beyond the expected: Identifying broad research priorities of researchers and the cystic fibrosis community

Hollin, I. L., Donaldson, S. H., Roman, C., Aliaj, E., Riva, D., Boyle, M. & Borowitz, D., Jan 1 2018, (Accepted/In press) In : Journal of Cystic Fibrosis.

Research output: Contribution to journalArticle

Cystic Fibrosis
Research Personnel
Research
Mental Health
Health
1 Citations

Changes in lung clearance index in preschool-aged patients with cystic fibrosis treated with ivacaftor (GOAL): A clinical trial

Ratjen, F., Klingel, M., Black, P., Powers, M. R., Grasemann, H., Solomon, M., Sagel, S. D., Donaldson, S. H., Rowe, S. M. & Rosenfeld, M., Aug 15 2018, In : American Journal of Respiratory and Critical Care Medicine. 198, 4, p. 526-528 3 p.

Research output: Contribution to journalLetter

Cystic Fibrosis
Clinical Trials
Lung
ivacaftor

Homogeneity of Aerosol Deposition and Mucociliary Clearance are Improved Following Ivacaftor Treatment in Cystic Fibrosis

Bennett, W. D., Zeman, K. L., Laube, B. L., Wu, J., Sharpless, G., Mogayzel, P. J. & Donaldson, S. H., Aug 1 2018, In : Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31, 4, p. 204-211 8 p.

Research output: Contribution to journalArticle

Mucociliary Clearance
Aerosols
Cystic Fibrosis
Lung
Therapeutics
2 Citations

Ivacaftor withdrawal syndrome in cystic fibrosis patients with the G551D mutation

Trimble, A. T. & Donaldson, S. H., Mar 1 2018, In : Journal of Cystic Fibrosis. 17, 2, p. e13-e16

Research output: Contribution to journalArticle

Cystic Fibrosis
Mutation
Withholding Treatment
Clinical Trials
Lung